---
schema_version: "secwatch.filing_event.v1"
accession: "0001437749-26-004245"
form_type: "8-K"
ticker: "NRXP"
cik: "0001719406"
company_name: "NRX Pharmaceuticals, Inc."
filed_at: "2026-02-17T23:59:59+00:00"
generated_at: "2026-05-16T02:27:54.948688+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.45
calibrated_materiality_score: 0.45
confidence: "high"
source: SEC EDGAR
---

# NRx Pharmaceuticals files $20M ATM offering for common stock

## Summary
- Filed prospectus supplement for up to $20M of common stock via ATM with H.C. Wainwright & Co.
- Shares to be issued under S-3 registration statement declared effective December 22, 2025.
- Legal opinion from Cozen O'Connor on share validity filed as Exhibit 5.1.
- No specific sales, pricing, or use of proceeds disclosed in the filing.

## SEC filing metadata
- accession: 0001437749-26-004245
- form_type: 8-K
- ticker: NRXP
- cik: 0001719406
- company_name: NRX Pharmaceuticals, Inc.
- filed_at: 2026-02-17T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.45
- calibrated_materiality_score: 0.45
- confidence: high
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1719406/000143774926004245/0001437749-26-004245-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1719406/000143774926004245/nrxp20260216_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001437749-26-004245
- JSON: https://secwatch.observer/filing/0001437749-26-004245.json
- Plain text: https://secwatch.observer/filing/0001437749-26-004245.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.